Tifenn Leturcq

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study

Muriel Elhaï, Marine Meunier, Marco Matucci‐Cerinic et al. · Annals of the Rheumatic Diseases · 2012 · 189 citations

Life Sciences, Immunology, Pharmacotherapy +16

Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study

Aurélien Sokal, Élisabeth Éléfant, Tifenn Leturcq et al. · Osteoporosis International · 2018 · 68 citations

Medicine, Obstetrics, Pediatrics +13

<i>ERAP1</i> Gene Expression Is Influenced by Nonsynonymous Polymorphisms Associated With Predisposition to Spondyloarthritis

Félicie Costantino, Alice Talpin, Irini Evnouchidou et al. · Arthritis & Rheumatology · 2015 · 67 citations

Life Sciences, Genetics, Molecular Genetics +10

Increased diagnostic accuracy of giant cell arteritis using three-dimensional fat-saturated contrast-enhanced vessel-wall magnetic resonance imaging at 3 T

Guillaume Poillon, Adrien Collin, Y. Benhamou et al. · European Radiology · 2019 · 46 citations

Medicine, Radiology, Biomedical Imaging +13